Szeto, Hazel H.

Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans

Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation

Mitochondrial Function and PathologyMetabolism, Diabetes, and Cancer

Cited by 1,253

Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury

Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry

Mitochondrial Function and PathologyCell death mechanisms and regulation

Cited by 782

Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer's disease neurons

Manczak, M., Mao, P., Calkins, M. J., Cornea, A., Reddy, A. P., Murphy, M. P., Szeto, H. H., Park, B., & Reddy, P. H. (2010) · Journal of Alzheimer's Disease

Alzheimer's disease research and treatmentsMitochondrial Function and Pathology

Cited by 469

Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease

Dai, D.-F., Chen, T., Johnson, S. C., Szeto, H., & Rabinovitch, P. S. (2012) · Antioxidants & Redox Signaling

Cardiovascular Function and Risk FactorsGenetics, Aging, and Longevity in Model Organisms

Cited by 334

Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents

Szeto, H. H. (2006) · The AAPS Journal

Mitochondrial Function and PathologyNeuroprotection in Cerebral Ischemia

Cited by 332

Cell-permeable, mitochondrial-targeted, peptide antioxidants

Szeto, H. H. (2006) · The AAPS Journal

Mitochondrial Function and PathologyFree Radicals and Antioxidants

Cited by 316

Mitochondrial-targeted antioxidants protect skeletal muscle against immobilization-induced muscle atrophy

Min, K., Smuder, A. J., Kwon, O.-S., Kavazis, A. N., Szeto, H. H., & Powers, S. K. (2011) · Journal of Applied Physiology

Muscle Physiology and DisordersExercise and Physiological Responses

Cited by 265

Mitochondria-targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness*

Powers, S. K., Hudson, M. B., Nelson, W. B., Talbert, E. E., Min, K., Szeto, H. H., Kavazis, A. N., & Smuder, A. J. (2011) · Critical Care Medicine

Muscle Physiology and DisordersRespiratory Support and Mechanisms

Cited by 255

Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines

Zhao, K., Luo, G., Giannelli, S., & Szeto, H. H. (2005) · Biochemical Pharmacology

Mitochondrial Function and PathologyCell death mechanisms and regulation

Cited by 251

Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

Petri, S., Kiaei, M., Damiano, M., Hiller, A., Wille, E., Manfredi, G., Calingasan, N. Y., Szeto, H. H., & Beal, M. F. (2006) · Journal of Neurochemistry

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 166

Potent mitochondria-targeted peptides reduce myocardial infarction in rats

Cho, J., Won, K., Wu, D., Soong, Y., Liu, S., Szeto, H. H., & Hong, M. K. (2007) · Coronary Artery Disease

Cardiac Ischemia and ReperfusionMitochondrial Function and Pathology

Cited by 144

Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases

Szeto, H. H. (2008) · Annals of the New York Academy of Sciences

Mitochondrial Function and PathologyParkinson's Disease Mechanisms and Treatments

Cited by 100

Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function

Thomas, D. A., Stauffer, C., Zhao, K., Yang, H., Sharma, V. K., Szeto, H. H., & Suthanthiran, M. (2007) · Journal of the American Society of Nephrology

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 84

[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors

Derick, S., Cheng, L. L., Voirol, M. J., Stoev, S., Giacomini, M., Wo, N. C., Szeto, H. H., Ben Mimoun, M., Andres, M., Gaillard, R. C., et al. (2002) · Endocrinology

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 76